List of Rx-risk comorbidity categories, corresponding Anatomical Therapeutic Chemical (ATC) codes, and score weightings in relation to 1-year mortality risk in Department of Veterans’ Affairs (DVA) and Pharmaceutical Benefits Scheme (PBS) data.
Rx-risk comorbidity category | ATC codes | DVA data | |
N (%) | Weights for Rx-Risk Score | ||
Alcohol dependency | N07BB01–N07BB99 | 183 (0.1) | 6 |
Allergies | R01AC01–R01AD60, R06AD02–R06AX27, R06AB04 | 16 684 (12) | −1 |
Anticoagulants | B01AA03–B01AB06, B01AE07, B01AF01, B01AF02, B01AX05 | 24 863 (18) | 1 |
Antiplatelets | B01AC04–B01AC30 | 52 525 (39) | 2 |
Anxiety | N05BA01–N05BA12, N05BE01 | 15 615 (12) | 1 |
Arrhythmia | C01AA05, C01BA01–C01BD01, C07AA07 | 14 992 (11) | 2 |
Benign prostatic hyperplasia | G04CA01–G04CA99, G04CB01, G04CB02* | 9003 (7) | 0 |
Bipolar disorder | N05AN01 | 231 (0.2) | −1 |
Chronic airways disease | R03AC02–R03DC03, R03DX05 | 33 244 (25) | 2 |
Congestive heart failure | C03DA02–C03DA99, C07AB02—if PBS item code is 8732N, 8733P, 8734Q, 8735R, C07AB07, C07AG02, C07AB12, C03DA04 (C03CA01–C03CC01 and C09AA01–C09AX99, C09CA01–C09CX99)† | 23 975 (8) | 2 |
Dementia | N06DA02–N06DA04, N06DX01 | 3868 (3) | 2 |
Depression | N06AA01–N06AG02, N06AX03–N06AX11, N06AX13–N06AX18, N06AX21–N06AX26 | 43 354 (32) | 2 |
Diabetes | A10AA01–A10BX99 | 17 550 (13) | 2 |
Epilepsy | N03AA01–N03AX99 | 15 484 (11) | 0 |
Glaucoma | S01EA01–S01EB03, S01EC03–S01EX99 | 16 262 (12) | 0 |
Gastrooesophageal reflux disease | A02BA01–A02BX05 | 69 358 (51) | 0 |
Gout | M04AA01–M04AC01 | 13 723 (10) | 1 |
Hepatitis B | J05AF08, J05AF10, J05AF11 | 7 (0.01) | NA |
Hepatitis C | J05AB54, L03AB10, L03AB11, L03AB60, L03AB61, J05AE14, J05AE11–J05AE12, J05AX14, J05AX15, J05AX65, J05AB04 | 1 (0.0) | NA |
HIV | J05AE01–J05AE10, J05AF12–J05AG05, J05AR01–J05AR99, J05AX07–J05AX09, J05AX12, J05AF01–J05AF07, J05AF09 | 42 (0.03) | 0 |
Hyperkalaemia | V03AE01 | 197 (0.2) | 4 |
Hyperlipidaemia | A10BH03‡, C10AA01–C10BX09 | 67 690 (50) | −1 |
Hypertension | C03AA01–C03BA11, C03DB01, C03DB99, C03EA01, C09BA02–C09BA09, C09DA02–C09DA08, C02AB01–C02AC05, C02DB02–C02DB99 (C03CA01–C03CCO1 or C09CA01–C09CX99)§ | 71 867 (53) | −1 |
Hyperthyroidism | H03BA02, H03BB01 | 992 (1) | 2 |
Hypothyroidism | H03AA01–H03AA02 | 13 438 (10) | 0 |
Irritable bowel syndrome | A07EC01–A07EC04, A07EA01–A07EA02, A07EA06, L04AA33 | 1132 (1) | 0 |
Ischaemic heart disease: angina | C01DA02–C01DA14, C01DX16, C08EX02 | 16 988 (13) | 2 |
Ischaemic heart disease: hypertension | C07AA01–C07AA06, C07AA08–C07AB01, C07AB02—if PBS item code is not 8732N, 8733P, 8734Q, 8735R, C07AG01, C08CA01–C08DB01, C09DB01–C09DB04, C09DX01, C09BB02–C09BB10, C07AB03, C09DX03, C10BX03¶ | 49 947 (37) | −1 |
Incontinence | G04BD01–G04BD99 | 5554 (4) | 0 |
Inflammation/pain | M01AB01–M01AH06 | 23 510 (17) | –1 |
Liver failure | A06AD11, A07AA11 | 5034 (4) | 3 |
Malignancies | L01AA01–L01XX41 | 7689 (6) | 2 |
Malnutrition | B05BA01–B05BA10 | 16 (0.01) | 0 |
Migraine | N02CA01–N02CX01 | 708 (1) | −1 |
Osteoporosis/Paget’s | M05BA01–M05BB05, M05BX03, M05BX04, G03XC01, H05AA02 | 21 448 (16) | −1 |
Pain | N02AA01–N02AX02, N02AX06, N02AX52, N02BE51 | 44 035 (33) | 3 |
Pancreatic insufficiency | A09AA02 | 433 (0.3) | 0 |
Parkinson’s disease | N04AA01–N04BX02 | 4237 (3) | 3 |
Psoriasis | D05AA01–D05AA99, D05BB01 D05BB02, D05AX02, D05AC01–D05AC51, D05AX52 | 1224 (1) | 0 |
Psychotic illness | N05AA01–N05AB02, N05AB06–N05AL07, N05AX07–N05AX13 | 7714 (6) | 6 |
Pulmonary hypertension | C02KX01–C02KX05, PBS item code 9547L, 9605M | 40 (0.03) | 6 |
Renal disease | B03XA01–B03XA03, A11CC01–A11CC04, V03AE02, V03AE03, V03AE05 | 1816 (1) | 6 |
Smoking cessation | N07BA01–N07BA03, N06AX12 | 1145 (1) | 6 |
Steroid-responsive disease | H02AB01–H02AB10 | 19 106 (14) | 2 |
Transplant | L04AA06, L04AA10, L04AA18, L04AD01, L04AD02 | 102 (0.1) | 0 |
Tuberculosis | J04AC01–J04AC51, J04AM01–J04AM99 | 0 | NA |
*Benign prostatic hyperplasia medicines are tested for gender—must be male. Females suffering from bladder obstructions can be prescribed medicines used to treat benign prostatic hyperplasia.
†Must have at least two medicines prescribed with one of those medicines having an ATC code from C03CA01–C03CC01 and the other having an ATC code from either C09AA01–C09AX99 or C09CA01–C09CX99.
‡Combination product for hyperlipidaemia and diabetes.
§Can have medicine dispensed with an ATC code C03CA01–C03CC01 or C09AA01–C09AX99, but not both, as this would indicate chronic heart failure.
¶Combination product for hyperlipidaemia and ischaemic heart disease: hypertension.
N/A, not applicable.